Eagle Pharmaceuticals Inc. (NASDAQ: EGRX)
$6.02
+0.0500 ( +0.84% ) 75.5K
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Market Data
Open
$6.02
Previous close
$5.97
Volume
75.5K
Market cap
$77.88M
Day range
$5.94 - $6.12
52 week range
$3.21 - $23.52
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Oct 24, 2023 |
8-k | 8K-related | 15 | Oct 23, 2023 |
4 | Insider transactions | 1 | Oct 04, 2023 |
8-k | 8K-related | 34 | Sep 27, 2023 |
8-k | 8K-related | 33 | Sep 07, 2023 |
8-k | 8K-related | 14 | Aug 29, 2023 |
8-k | 8K-related | 14 | Aug 17, 2023 |
10-q/a | Quarterly Reports | 83 | Aug 09, 2023 |
10-q | Quarterly Reports | 81 | Aug 08, 2023 |
8-k | 8K-related | 15 | Aug 08, 2023 |